-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
-
Summary
-
Enlivex Therapeutics Ltd. quarterly Deferred Tax Assets, Gross history and growth rate from Q4 2013 to Q4 2023.
- Enlivex Therapeutics Ltd. Deferred Tax Assets, Gross for the quarter ending December 31, 2023 was $22.3M, a 23.1% decline year-over-year.
Deferred Tax Assets, Gross, Quarterly (USD)
Deferred Tax Assets, Gross, YoY Quarterly Growth (%)